Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1996-8-13
pubmed:abstractText
The IgM monoclonal autoantibodies of patients with demyelinating paraproteinaemic polyneuropathy recognize a carbohydrate structure present on both myelin-associated glycoprotein (MAG) and protein zero (P0). These autoantibodies are sufficient to cause the disease but the mechanism of demyelination remains unclear. We have analysed nerve biopsies from eight patients with polyneuropathy and anti-MAG antibodies by quantitative immunohistochemistry and find a concordant pattern of reduced expression of myelin markers with the loss of myelinated fibres. We report here novel features of this disease, in particular a selective lack of detectable MAG in a large proportion of myelinated-fibres containing P0, myelin basic protein (MBP) and periaxin. There is also an inverse correlation of the distribution of MAG in peripheral nerve myelin with the serum anti-MAG antibody titres but no correlation of these titres with the loss of myelinated fibres. Double immunofluorescence staining of paraproteinaemic polyneuropathy (PPN) nerves shows anti-MAG IgM deposited on the periphery of myelinated fibres associated with or lacking MAG staining. These data suggest that the binding of anti-MAG antibodies to MAG and/or other myelin component(s) results in MAG downregulation and may have an essential role in the molecular mechanisms leading to demyelination and partial regeneration in this disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0006-8950
pubmed:author
pubmed:issnType
Print
pubmed:volume
119 ( Pt 3)
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
775-87
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8673490-Antibody Specificity, pubmed-meshheading:8673490-Antigens, CD57, pubmed-meshheading:8673490-Autoantibodies, pubmed-meshheading:8673490-Biological Markers, pubmed-meshheading:8673490-Biopsy, pubmed-meshheading:8673490-Demyelinating Diseases, pubmed-meshheading:8673490-Female, pubmed-meshheading:8673490-Fluorescent Antibody Technique, pubmed-meshheading:8673490-Glial Fibrillary Acidic Protein, pubmed-meshheading:8673490-Humans, pubmed-meshheading:8673490-Immunoglobulin M, pubmed-meshheading:8673490-Immunohistochemistry, pubmed-meshheading:8673490-Male, pubmed-meshheading:8673490-Myelin Proteins, pubmed-meshheading:8673490-Myelin Sheath, pubmed-meshheading:8673490-Myelin-Associated Glycoprotein, pubmed-meshheading:8673490-Paraproteinemias, pubmed-meshheading:8673490-Peripheral Nervous System Diseases, pubmed-meshheading:8673490-Peroneal Nerve, pubmed-meshheading:8673490-Staining and Labeling
pubmed:year
1996
pubmed:articleTitle
Selective loss of myelin-associated glycoprotein from myelin correlates with anti-MAG antibody titre in demyelinating paraproteinaemic polyneuropathy.
pubmed:affiliation
Department of Research, University Hospital Basel, Switzerland.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't